18. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, et al. (2010) Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32: 317–328. 19. Wei GH, Badis G, Berger MF, Kivioja T, Palin K, et al. (2010) Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J 29: 2147–2160. 20. Lefterova MI, Steger DJ, Zhuo D, Qatanani M, Mullican SE, et al. (2010) Cell- specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages. Mol Cell Biol 30: 2078–2089. 21. Le Clech M, Chalhoub E, Dohet C, Roure V, Fichelson S, et al. (2006) PU.1/ Spi-1 binds to the human TAL-1 silencer to mediate its activity. J Mol Biol 355: 9–19. 22. Calero-Nieto FJ, Wood AD, Wilson NK, Kinston S, Landry JR, et al. (2010) Transcriptional regulation of Elf-1: locus-wide analysis reveals four distinct promoters, a tissue-specific enhancer, control by PU.1 and the importance of Elf-1 downregulation for erythroid maturation. Nucleic Acids Res 38: 6363–6374. 23. Dolznig H, Kolbus A, Leberbauer C, Schmidt U, Deiner EM, et al. (2005) Expansion and differentiation of immature mouse and human hematopoietic progenitors. Methods Mol Med 105: 323–344. 24. Ji H, Jiang H, Ma W, Johnson DS, Myers RM, et al. (2008) An integrated software system for analyzing ChIP-chip and ChIP-seq data. Nat Biotechnol 26: 1293–1300. 25. Kharchenko PV, Tolstorukov MY, Park PJ (2008) Design and analysis of ChIP- seq experiments for DNA-binding proteins. Nat Biotechnol 26: 1351–1359. 26. Bailey TL, Elkan C (1994) Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 2: 28–36. 27. Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA (1990) The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61: 113–124. 28. Karim FD, Urness LD, Thummel CS, Klemsz MJ, McKercher SR, et al. (1990) The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence. Genes Dev 4: 1451–1453. 29. Wilson NK, Foster SD, Wang X, Knezevic K, Schutte J, et al. (2010) Combinatorial Transcriptional Control In Blood Stem/Progenitor Cells: Genome-wide Analysis of Ten Major Transcriptional Regulators. Cell Stem Cell 7: 532–544. 30. Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, et al. (2004) Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 36: 624–630. 31. Zhang J, Socolovsky M, Gross AW, Lodish HF (2003) Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood 102: 3938–3946. 32. Rosenbauer F, Owens BM, Yu L, Tumang JR, Steidl U, et al. (2006) Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat Genet 38: 27–37. 33. Steidl U, Rosenbauer F, Verhaak RG, Gu X, Ebralidze A, et al. (2006) Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat Genet 38: 1269–1277. 34. Pereira R, Quang CT, Lesault I, Dolznig H, Beug H, et al. (1999) FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts. Oncogene 18: 1597–1608. 35. Starck J, Doubeikovski A, Sarrazin S, Gonnet C, Rao G, et al. (1999) Spi-1/ PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines. Mol Cell Biol 19: 121–135. 36. Cuddihy AE, Brents LA, Aziz N, Bender TP, Kuehl WM (1993) Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells. Mol Cell Biol 13: 3505–3513. 37. McClinton D, Stafford J, Brents L, Bender TP, Kuehl WM (1990) Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene. Mol Cell Biol 10: 705–710. 38. Saleque S, Cameron S, Orkin SH (2002) The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev 16: 301–306. 39. Wu H, Liu X, Jaenisch R, Lodish HF (1995) Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83: 59–67. 40. Nuez B, Michalovich D, Bygrave A, Ploemacher R, Grosveld F (1995) Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 375: 316–318. 41. Perkins AC, Sharpe AH, Orkin SH (1995) Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 375: 318–322. 42. Okuno Y, Huang G, Rosenbauer F, Evans EK, Radomska HS, et al. (2005) Potential autoregulation of transcription factor PU.1 by an upstream regulatory element. Mol Cell Biol 25: 2832–2845. 43. Rimmele P, Kosmider O, Mayeux P, Moreau-Gachelin F, Guillouf C (2007) Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation. Blood 109: 3007–3014. 44. Ota M, Sasaki H (2008) Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 135: 4059–4069. PU.1-Directed Gene Networks in Erythroid Cells 45. Li FX, Zhu JW, Hogan CJ, DeGregori J (2003) Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice. Mol Cell Biol 23: 3607–3622. 46. Humbert PO, Rogers C, Ganiatsas S, Landsberg RL, Trimarchi JM, et al. (2000) E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol Cell 6: 281–291. 47. Kinross KM, Clark AJ, Iazzolino RM, Humbert PO (2006) E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation. Blood 108: 886–895. 48. Dirlam A, Spike BT, Macleod KF (2007) Deregulated E2f-2 underlies cell cycle and maturation defects in retinoblastoma erythroblasts. Mol Cell Biol 27: 8713–8728. 49. Weigelt K, Lichtinger M, Rehli M, Langmann T (2009) Transcriptomic profiling identifies a PU.1 regulatory network in macrophages. Biochem Biophys Res Commun 380: 308–312. 50. Rekhtman N, Choe KS, Matushansky I, Murray S, Stopka T, et al. (2003) PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation. Mol Cell Biol 23: 7460–7474. 51. Yu M, Riva L, Xie H, Schindler Y, Moran TB, et al. (2009) Insights into GATA- 1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol Cell 36: 682–695. 52. Fujiwara T, O’Geen H, Keles S, Blahnik K, Linnemann AK, et al. (2009) Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol Cell 36: 667–681. 53. Soler E, Andrieu-Soler C, de Boer E, Bryne JC, Thongjuea S, et al. (2010) The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation. Genes Dev 24: 277–289. 54. Cheng Y, Wu W, Kumar SA, Yu D, Deng W, et al. (2009) Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res 19: 2172–2184. 55. Kassouf MT, Hughes JR, Taylor S, McGowan SJ, Soneji S, et al. (2010) Genome-wide identification of TAL1’s functional targets: insights into its mechanisms of action in primary erythroid cells. Genome Res 20: 1064–1083. 56. Tallack MR, Whitington T, Yuen WS, Wainwright EN, Keys JR, et al. (2010) A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells. Genome Res 20: 1052–1063. 57. Matushansky I, Radparvar F, Skoultchi AI (2003) CDK6 blocks differentiation: coupling cell proliferation to the block to differentiation in leukemic cells. Oncogene 22: 4143–4149. 58. Tamir A, Howard J, Higgins RR, Li YJ, Berger L, et al. (1999) Fli-1, an Ets- related transcription factor, regulates erythropoietin-induced erythroid prolifer- ation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol 19: 4452–4464. 59. Starck J, Cohet N, Gonnet C, Sarrazin S, Doubeikovskaia Z, et al. (2003) Functional cross-antagonism between transcription factors FLI-1 and EKLF. Mol Cell Biol 23: 1390–1402. 60. Ano S, Pereira R, Pironin M, Lesault I, Milley C, et al. (2004) Erythroblast transformation by FLI-1 depends upon its specific DNA binding and transcriptional activation properties. J Biol Chem 279: 2993–3002. 61. Barnache S, Mayeux P, Payrastre B, Moreau-Gachelin F (2001) Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythro- blasts. Blood 98: 2372–2381. 62. Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF (1999) Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98: 181–191. 63. Bone HK, Welham MJ (2007) Phosphoinositide 3-kinase signalling regulates early development and developmental haemopoiesis. J Cell Sci 120: 1752–1762. 64. Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, et al. (1998) Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93: 385–395. 65. Breig O, Theoleyre O, Douablin A, Baklouti F (2010) Subtle distinct regulations of late erythroid molecular events by PI3K/AKT-mediated activation of Spi-1/ PU.1 oncogene autoregulation loop. Oncogene. 66. Hegde S, Ni S, He S, Yoon D, Feng GS, et al. (2009) Stat3 promotes the development of erythroleukemia by inducing Pu.1 expression and inhibiting erythroid differentiation. Oncogene 28: 3349–3359. 67. DeKoter RP, Singh H (2000) Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288: 1439–1441. 68. Nutt SL, Metcalf D, D’Amico A, Polli M, Wu L (2005) Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J Exp Med 201: 221–231. 69. Back J, Allman D, Chan S, Kastner P (2005) Visualizing PU.1 activity during hematopoiesis. Exp Hematol 33: 395–402. 70. Xie H, Ye M, Feng R, Graf T (2004) Stepwise reprogramming of B cells into macrophages. Cell 117: 663–676. 71. Burda P, Curik N, Kokavec J, Basova P, Mikulenkova D, et al. (2009) PU.1 activation relieves GATA-1-mediated repression of Cebpa and Cbfb during leukemia differentiation. Mol Cancer Res 7: 1693–1703. 72. Yamada T, Abe M, Higashi T, Yamamoto H, Kihara-Negishi F, et al. (2001) Lineage switch induced by overexpression of Ets family transcription factor PU.1 in murine erythroleukemia cells. Blood 97: 2300–2307. PLoS Genetics | www.plosgenetics.org 14 June 2011 | Volume 7 | Issue 6 | e1001392